[{"address1": "5217 Winnebago Lane", "city": "Austin", "state": "TX", "zip": "78744", "country": "United States", "phone": "512 386 2900", "fax": "512 386 5505", "website": "https://www.xbiotech.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.", "fullTimeEmployees": 85, "companyOfficers": [{"maxAge": 1, "name": "Mr. John  Simard", "age": 61, "title": "Founder, President, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": 4670934, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sushma  Shivaswamy Ph.D.", "age": 45, "title": "Chief Scientific Officer", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": 381240, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Hu", "age": 39, "title": "Director of Finance, Principal Financial & Accounting Officer and Financial Controller", "yearBorn": 1984, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 5, "overallRisk": 8, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 6.4, "open": 6.46, "dayLow": 6.23, "dayHigh": 6.46, "regularMarketPreviousClose": 6.4, "regularMarketOpen": 6.46, "regularMarketDayLow": 6.23, "regularMarketDayHigh": 6.46, "exDividendDate": 1626307200, "beta": 1.429, "forwardPE": 48.846153, "volume": 27064, "regularMarketVolume": 27064, "averageVolume": 38031, "averageVolume10days": 43720, "averageDailyVolume10Day": 43720, "bidSize": 1100, "askSize": 800, "marketCap": 193274944, "fiftyTwoWeekLow": 3.05, "fiftyTwoWeekHigh": 7.24, "priceToSalesTrailing12Months": 644.2498, "fiftyDayAverage": 5.3086, "twoHundredDayAverage": 4.856425, "currency": "USD", "enterpriseValue": -8916279, "floatShares": 17078181, "sharesOutstanding": 30437000, "sharesShort": 537487, "sharesShortPriorMonth": 376512, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.0177, "heldPercentInsiders": 0.36039, "heldPercentInstitutions": 0.15162, "shortRatio": 9.91, "shortPercentOfFloat": 0.026600001, "bookValue": 7.315, "priceToBook": 0.86807925, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -23125000, "trailingEps": -0.75, "forwardEps": 0.13, "enterpriseToRevenue": -29.721, "enterpriseToEbitda": 0.252, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "XBIT", "underlyingSymbol": "XBIT", "shortName": "XBiotech Inc.", "longName": "XBiotech Inc.", "firstTradeDateEpochUtc": 1429104600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "fb07a30b-f4ae-35af-9fbb-83dba861caeb", "gmtOffSetMilliseconds": -14400000, "currentPrice": 6.35, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 202191008, "totalCashPerShare": 6.643, "ebitda": -35332000, "quickRatio": 38.444, "currentRatio": 38.61, "totalRevenue": 300000, "revenuePerShare": 0.01, "returnOnAssets": -0.09649, "returnOnEquity": -0.09894, "freeCashflow": -15360125, "operatingCashflow": -18456000, "grossMargins": 0.94667, "operatingMargins": -123.61667, "financialCurrency": "USD", "trailingPegRatio": null}]